The differential response to TNF-α and metformin in IR individuals, compared to their IS counterparts, suggests that targeting adipose tissue dysfunction and enhancing adipogenesis could be a promising therapeutic strategy against insulin resistance and its associated metabolic consequences, highlighting the need for a deeper understanding of the molecular mechanisms linking adipocyte phenotype and insulin resistance. This evidence concerns the gene TNF and Insulin resistance.